Management Name : Mr PHEEYAVANTHA TREEANEKVAANICH | Type of securities : Warrant | Methods of Acquisition / Disposition : Sell | Transaction Date : 05/04/2018
Management Name : Mr PHEEYAVANTHA TREEANEKVAANICH | Type of securities : Warrant | Methods of Acquisition / Disposition : Sell | Transaction Date : 11/04/2018
Management Name : Mr PHEEYAVANTHA TREEANEKVAANICH | Type of securities : Warrant | Methods of Acquisition / Disposition : Sell | Transaction Date : 17/04/2018
Management Name : Mr PHEEYAVANTHA TREEANEKVAANICH | Type of securities : Warrant | Methods of Acquisition / Disposition : Sell | Transaction Date : 20/04/2018
in support of the campaign, “One of the SEC key strategic goals is to encourage people to save and invest in the capital market for their good financial health and long-term financial goals. We are of
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 HEALTH
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Company Q3 30/09/2022 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Consolidated Q3 30/09/2022 HEALTH
Derivative Warrants | ALIHEA28C2409A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY MACQUARIE SECURITIES (THAILAND) LIMITED LAST TRADING IN SEPTEMBER 2024
Derivative Warrants | ALIHEA41C2410A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN OCTOBER 2024